CME
February 14, 2024 - AI Summary
Overvalued by 7.3% based on the discounted cash flow analysis.
Market cap | $76.52 Billion |
---|---|
Enterprise Value | $78.39 Billion |
Dividend Yield | $9.4313 (4.43%) |
Earnings per Share | $8.78 |
Beta | 0.21 |
Outstanding Shares | 359,700,000 |
Avg 30 Day Volume | 1,804,333 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 24.24 |
---|---|
PEG | -747.36 |
Price to Sales | 14.21 |
Price to Book Ratio | 2.84 |
Enterprise Value to Revenue | 13.93 |
Enterprise Value to EBIT | 20.7 |
Enterprise Value to Net Income | 24 |
Total Debt to Enterprise | 0.04 |
Debt to Equity | 0.13 |
No data
No data